New Study Validates Caffinity™ from FutureCeuticals for Energy and Performance Boosts
In a world where functional supplements are increasingly important for athletes and active individuals, FutureCeuticals, Inc. has made a groundbreaking announcement. A peer-reviewed clinical study has shed light on the impressive benefits of Caffinity™, the brand's proprietary ingredient derived from the Arabica coffee cherry. Conducted by trusted experts at the University of Exeter in the United Kingdom, the study confirms Caffinity as the first clinically validated energy-enhancing ingredient that combines caffeine and polyphenols from coffee cherries.
The randomized, double-blind, placebo-controlled trial involved participants who were trained cyclists. The results were compelling: a dose of 286 mg of Caffinity, which includes 200 mg of caffeine and a blend of polyphenols, led to nearly a 5% increase in overall cycling performance compared to a placebo group (P < 0.05). Beyond athletic performance, participants reported a perception of reduced effort during rigorous training sessions, suggesting that Caffinity’s benefits extend across various intensities.
An especially notable finding from the study was Caffinity’s potential impact during recovery periods. The researchers observed that Caffinity promoted enhanced fat mobilization and increased availability of ketone bodies, which in turn prepares the body for improved metabolic flexibility. Additionally, the ingredient helped stabilize blood sugar levels and prevent the spikes commonly associated with traditional caffeine dosages during exercise.
One of the most exciting aspects of the results was the finding regarding lactate levels post-exercise. With the use of Caffinity, participants experienced a quicker reduction in lactate levels, with their bodies returning to baseline conditions in a timely manner, fostering faster recovery times.
J. Randal Wexler, General Counsel and VP of Research and Development at FutureCeuticals, emphasized the importance of these findings. "These compelling results reinforce our commitment to providing clean, scientifically-backed energy solutions at lower dosages that cater to today’s active consumer needs,” he stated. Wexler further explained that Caffinity not only enhances performance but also allows for improved metabolic recovery and steadier blood sugar control, significantly setting it apart from standard functional caffeine doses.
Caffinity is sustainably sourced from family-owned farms, ensuring responsible agriculture practices. Unlike synthetic caffeine or isolated extracts, Caffinity is standardized to contain 70% natural caffeine and 5% natural polyphenols, offering a complex that assures health-conscious consumers.
Overall, the findings from this pivotal study present Caffinity as a groundbreaking option for athletes aiming to optimize their performance nutrition strategies. With its proven ability to provide a healthier alternative to stimulants without compromising results, Caffinity represents a new era in performance enhancement for both athletes and fitness enthusiasts alike.
FutureCeuticals, Inc. is the exclusive developer of Caffinity™ and an industry leader in the research, development, and manufacturing of plant-based powders and extracts for functional food, beverage, and dietary supplement markets.
The randomized, double-blind, placebo-controlled trial involved participants who were trained cyclists. The results were compelling: a dose of 286 mg of Caffinity, which includes 200 mg of caffeine and a blend of polyphenols, led to nearly a 5% increase in overall cycling performance compared to a placebo group (P < 0.05). Beyond athletic performance, participants reported a perception of reduced effort during rigorous training sessions, suggesting that Caffinity’s benefits extend across various intensities.
An especially notable finding from the study was Caffinity’s potential impact during recovery periods. The researchers observed that Caffinity promoted enhanced fat mobilization and increased availability of ketone bodies, which in turn prepares the body for improved metabolic flexibility. Additionally, the ingredient helped stabilize blood sugar levels and prevent the spikes commonly associated with traditional caffeine dosages during exercise.
One of the most exciting aspects of the results was the finding regarding lactate levels post-exercise. With the use of Caffinity, participants experienced a quicker reduction in lactate levels, with their bodies returning to baseline conditions in a timely manner, fostering faster recovery times.
J. Randal Wexler, General Counsel and VP of Research and Development at FutureCeuticals, emphasized the importance of these findings. "These compelling results reinforce our commitment to providing clean, scientifically-backed energy solutions at lower dosages that cater to today’s active consumer needs,” he stated. Wexler further explained that Caffinity not only enhances performance but also allows for improved metabolic recovery and steadier blood sugar control, significantly setting it apart from standard functional caffeine doses.
Caffinity is sustainably sourced from family-owned farms, ensuring responsible agriculture practices. Unlike synthetic caffeine or isolated extracts, Caffinity is standardized to contain 70% natural caffeine and 5% natural polyphenols, offering a complex that assures health-conscious consumers.
Overall, the findings from this pivotal study present Caffinity as a groundbreaking option for athletes aiming to optimize their performance nutrition strategies. With its proven ability to provide a healthier alternative to stimulants without compromising results, Caffinity represents a new era in performance enhancement for both athletes and fitness enthusiasts alike.
FutureCeuticals, Inc. is the exclusive developer of Caffinity™ and an industry leader in the research, development, and manufacturing of plant-based powders and extracts for functional food, beverage, and dietary supplement markets.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.